Insider · CIK 0001606831
Lawson Macartney
Files at VKTX (Viking Therapeutics, Inc.). First filing Nov 8, 2024, latest Nov 8, 2024.
Lawson Macartney files SEC Form 4 as director at VKTX (Viking Therapeutics, Inc.). Since Nov 8, 2024, Lawson Macartney has reported 0 open-market buys worth $0 and 1 open-market sell worth $137k, the latest filed on Nov 8, 2024.
A track record needs three past buys with six months of prices behind them; Lawson Macartney has 0, so none is measured yet.
The newest scored trade: sold $137k of VKTX on Nov 8, 2024, filed Nov 8, 2024, scored 26 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VKTX: Viking Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | Viking Therapeutics, Inc. | $137k 2,000 shares | -4% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 8, 2024 | VKTX VIKING THERAPEUTICS, INC. | 2,000 0.00% of outstanding | $137k | Nov 8, 2024 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc. | AGrant or award Common Stock, par value $0.00001 per share | +3,150 | $0.00 | $0 | 51,115 | Jan 5, 2026 |
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +20,400 | $0.00 | $0 | 20,400 | Jan 5, 2026 |
| Nov 8, 2024 | VKTX Viking Therapeutics, Inc. | MOption exercise Common Stock, par value $0.00001 per share | +2,000 | $5.80 | $12k | 49,965 | Nov 8, 2024 |
| Nov 8, 2024 | VKTX Viking Therapeutics, Inc. | SOpen-market sale Common Stock, par value $0.00001 per share | -2,000 | $68.67 | $137k | 47,965 | Nov 8, 2024 |
| Nov 8, 2024 | VKTX Viking Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -2,000 | $0.00 | $0 | 20,000 | Nov 8, 2024 |
Questions about Lawson Macartney
Answered from the filings on this page, as of the latest one.
Is Lawson Macartney buying or selling?
Not in the last 12 months. Lawson Macartney's latest open-market trade on SEC Form 4 was sold $137k of VKTX on Nov 8, 2024.
How did Lawson Macartney's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lawson Macartney has 0.
Where does Lawson Macartney file Form 4?
Lawson Macartney has filed Form 4 at VKTX (Viking Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.